Health Trials

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer

This study was a randomized, double-blind, multi-center phase III clinical trial to evaluate the event-free survival (EFS) of Adebrelimab with S-1 and oxaliplatin versus placebo combined with S-1 and oxaliplatin, and to evaluate the efficacy, safety and tolerability of the two combination regimens.

Participants needed: 874
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Shengdi Pharmaceutical Co., LtdUpdated: May 13, 2026Locations: 1
Eligibility criteria

Patients with pathologically confirmed gastric cancer or gastroesophageal juncti... [+9]

Gastric cancer known to be squamous cell carcinoma, undifferentiated carcinoma o... [+15]

Read more
Status: Recruiting

A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

This study aims to evaluate the efficacy of Adebrelimab plus concurrent chemoradiotherapy compared with placebo plus concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer by evaluating progression-free survival (PFS).

Participants needed: 720
Trial details
Phase: Phase 3Age: 18-75Biological sex: FemaleType: InterventionalSponsor: Shanghai Shengdi Pharmaceutical Co., LtdUpdated: Apr 15, 2026Locations: 1
Eligibility criteria

Participate in the study voluntarily, sign the informed consent form. [+5]

Pathologically or radiologically confirmed presence of distant metastatic diseas... [+7]

Read more
Status: Recruiting

A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors

This study is an open, multicenter Phase I/II clinical trial, divided into two stages: dose exploration (including dose escalation and dose extension) and efficacy extension.

Participants needed: 258
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Shengdi Pharmaceutical Co., LtdUpdated: Jan 9, 2026Locations: 1
Eligibility criteria

Subjects must voluntarily agree to participate in the trial and sign a written i... [+6]

Patients with active central nervous system metastases or meningeal metastases; [+5]

Read more
Status: Not yet recruiting

A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

Evaluating the Efficacy and safety of Adebrelimab in Combination with Platinum-based Doublet Chemotherapy and SHR-8068 as First-line Therapy for Patients with Advanced or Metastatic NSCLC Carrying STK11/KEAP1/KRAS Mutations

Participants needed: 401
Trial details
Phase: Phase 2, Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Shengdi Pharmaceutical Co., LtdUpdated: Mar 28, 2024Locations: 1
Eligibility criteria

The participant voluntarily joins this clinical research study, understands the... [+6]

Pathologically or cytologically confirmed mixed Small Cell Lung Cancer (SCLC), s... [+19]

Read more